Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.23 USD | +1.95% | 0.00% | +1.75% |
Business Summary
Number of employees: 31
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Berman
CEO | Chief Executive Officer | 61 | 31/03/18 |
Craig Glynn
DFI | Director of Finance/CFO | 63 | 05/04/20 |
Hamed Alavi
CTO | Chief Tech/Sci/R&D Officer | - | 29/12/20 |
Marc Glickman
CTO | Chief Tech/Sci/R&D Officer | 75 | 30/04/16 |
Kevin Belteau
PRN | Corporate Officer/Principal | - | 15/08/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Berman
CEO | Chief Executive Officer | 61 | 31/03/18 |
Director/Board Member | 63 | 15/09/19 | |
Marc Glickman
CTO | Chief Tech/Sci/R&D Officer | 75 | 30/04/16 |
Francis Duhay
BRD | Director/Board Member | 64 | 01/10/18 |
Director/Board Member | 57 | 01/10/18 | |
Robert Gray
BRD | Director/Board Member | 77 | 15/09/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,317,000 | 12,642,470 ( 94.93 %) | 0 | 94.93 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.75% | 68.31M | |
+17.95% | 42.68B | |
-1.35% | 42.4B | |
+46.56% | 40.04B | |
-6.20% | 28.31B | |
+6.96% | 24.94B | |
-21.69% | 18.96B | |
+29.57% | 12.3B | |
-1.08% | 11.95B | |
-4.50% | 11.55B |
- Stock Market
- Equities
- NVNO Stock
- Company enVVeno Medical Corporation